Zandelisib - CAS 1401436-95-0
Zandelisib (ME-401) is a phosphatidylinositol 3-kinase (PI3K) inhibitor extracted from patent WO2019183226 A1, Compound Example 1. Zandelisib selectively inhibits p110δ with an IC50 of 3.5 nM. Zandelisib functions as an antineoplastic[1][2].
Zandelisib inhibits PI3Ks with IC50s of 4, 976 nM, 605 nM, 817 nM and 3.5 nM for p110α, p110β, p110γ and p110δ, respectivey[1].
Catalog Number: I015424
CAS Number: 1401436-95-0
Molecular Formula: C₃₁H₃₈F₂N₈O
Molecular Weight:576.68
Purity: ≥95%
* For research use only. Not for human or veterinary use.
Property
Molecular Formula: | C₃₁H₃₈F₂N₈O |
---|---|
Molecular Weight | 576.68 |
Purity | ≥95% |